Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line

被引:3
|
作者
Weidemann, Heidrun [1 ]
Feger, Daniel [2 ]
Ehlert, Jan E. E. [2 ]
Menger, Marcus M. [3 ]
Krempien, Robert C. C. [1 ]
机构
[1] HELIOS Hosp Berlin Buch, Clin Radiotherapy, Schwanebecker Chaussee 50, D-13125 Berlin, Germany
[2] React Biol Europe GmbH, Engesserstr4, D-79108 Freiburg, Germany
[3] Fraunhofer Inst Cell Therapy & Immunol, Branch Bioanalyt & Bioproc, IZI, BB, Muhlenberg13, D-14476 Potsdam, Germany
关键词
Bcl-2; Cell migration; Chemoresistance; Glioblastoma; Na; K-ATPase; Ouabain; Pan-Akt; Plasma cell membrane potential; BCL-2 FAMILY PROTEINS; ENDOGENOUS OUABAIN; NA+/K+-ATPASE; CARDIAC-GLYCOSIDES; IN-VITRO; MEMBRANE HYPERPOLARIZATION; THERAPEUTIC CONCENTRATIONS; ADJUVANT TEMOZOLOMIDE; ANTICANCER AGENT; PLASMA-MEMBRANE;
D O I
10.1007/s12672-023-00633-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundGlioblastoma multiforme (GBM) is the most aggressive primary brain tumor with poor prognosis. GMB are highly recurrent mainly because of radio- and chemoresistance. Radiotherapy with Temozolomide (TMZ) is until today the golden standard adjuvant therapy, however, the optimal treatment of recurrent glioblastoma remains controversial. Ouabain belongs to the Cardiotonic Steroids (CTS) the natural ligands of the Na/K-ATPase (NKA). It is established that the NKA represents a signal transducer with either stimulating or inhibiting cell growth, apoptosis, migration and angiogenesis. Over the last decade evidence grew that CTS have anti-tumor properties especially in GBM.AimProceeding from recent studies we wanted to further demonstrate a divergent effect of Ouabain on a TMZ-resistant (T98G) as compared to a TMZ-sensitive (LN229) GBM cell line.MethodsWe analyzed the effect of Ouabain on cell migration and plasma cell membrane potential (PCMP) in the LN229 and T98G GBM cell line as well as underlying mechanisms (Bcl-2 and p-Akt/pan-Akt expression). Moreover, we analyzed the anti-angiogenic effect of Ouabain on human umbilical vein endothelial cells (HUVECs).ResultsT98G cells showed a significant inhibition of cell migration and a significant depolarization of the PCMP at similar Ouabain concentrations (IC50 = 1.67 x 10(-7) M) resp. (IC50 = 2.72 x 10(-7) M) with a strong inverse correlation (R-2 = 0.95). In contrast, LN229 cells did not respond to Ouabain in these assays at all. Similarly, only T98G but not LN229 cells revealed Bcl-2 down-regulation at nanomolar Ouabain concentrations. This unique response to Ouabain is associated with a down-regulation of pan-Akt in T98G cells 24 h after Ouabain (1.0 x 10(-6) M) treatment. For the first time, the anti-angiogenic effect of Ouabain on HUVEC cells (IC50 = 5.49 x 10(-8) M) was demonstrated which correlated strongly with the anti-migratory effect (R-2 = 0.85).ConclusionThe TMZ-resistant T98G cell line as compared to the TMZ-sensitive LN229 cell line shows a high sensitivity towards Ouabain. We consider it as a promising new compound especially in recurrent GBM to overcome the resistance to TMZ and irradiation.
引用
收藏
页数:16
相关论文
共 18 条
  • [1] Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line
    Heidrun Weidemann
    Daniel Feger
    Jan E. Ehlert
    Marcus M. Menger
    Robert C. Krempien
    Discover Oncology, 14
  • [2] Temozolomide-Resistant Human T2 and T98G Glioblastoma Cells
    Pinevich A.A.
    Bode I.I.
    Vartanyan N.L.
    Kiseleva L.N.
    Kartashev A.V.
    Samoilovich M.P.
    Cell and Tissue Biology, 2022, 16 (4) : 339 - 351
  • [3] Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide
    Ana P. Montaldi
    Elza T. Sakamoto-Hojo
    Clinical and Experimental Medicine, 2013, 13 : 279 - 288
  • [4] Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide
    Montaldi, Ana P.
    Sakamoto-Hojo, Elza T.
    CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 13 (04) : 279 - 288
  • [5] The effects of the combination of temozolomide and Eribulin on T98G human glioblastoma cell line: an ultrastructural study
    Tanriverdi, Gamze
    Kaleci, Belisa
    Yavuz, Furkan
    Sahin, Hakan
    Purelku, Merjem
    Yazici, Zeliha
    Kokturk, Sibel
    ULTRASTRUCTURAL PATHOLOGY, 2024, 48 (05) : 323 - 337
  • [6] Inhibitory effect of temozolomide on apoptosis induction of cinnamaldehyde in human glioblastoma multiforme T98G cell line
    Abband, Hedieh
    Dabirian, Sara
    Jafari, Adele
    Nasiri, Mehran
    Nasiri, Ebrahim
    ANATOMY & CELL BIOLOGY, 2024, 57 (01) : 85 - 96
  • [7] Corilagin Induces High Levels of Apoptosis in the Temozolomide- Resistant T98G Glioma Cell Line
    Milani, Roberta
    Brognara, Eleonora
    Fabbri, Enrica
    Finotti, Alessia
    Borgatti, Monica
    Lampronti, Ilaria
    Marzaro, Giovanni
    Chilin, Adriana
    Lee, Kenneth Ka-Ho
    Kok, Stanton Hon-Lung
    Chui, Chung-Hin
    Gambari, Roberto
    ONCOLOGY RESEARCH, 2018, 26 (09) : 1307 - 1315
  • [8] Inhibitory effect of temozolomide on apoptosis induction of cinnamaldehyde in human glioblastoma multiforme T98G cell line (vol 57, pg 85, 2024)
    Abband, Hedieh
    Dabirian, Sara
    Jafari, Adele
    Nasiri, Mehran
    Nasiri, Ebrahim
    ANATOMY & CELL BIOLOGY, 2024, 57 (02) : 332 - 332
  • [9] Effects of kaempferol on the mechanisms of drug resistance in the human glioblastoma cell line T98G
    Nakatsuma, A.
    Fukami, T.
    Suzuki, T.
    Furuishi, T.
    Tomono, K.
    Hidaka, S.
    PHARMAZIE, 2010, 65 (05): : 379 - 383
  • [10] miR-222/GAS5 is involved in DNA damage and cytotoxic effects induced by temozolomide in T98G cell line
    Huang, Haoyu
    Jiang, Ran
    Lian, Zhenwei
    Zhang, Wenjuan
    Hu, Zuqing
    Hu, Dalin
    JOURNAL OF APPLIED TOXICOLOGY, 2019, 39 (05) : 726 - 734